Cardiovascular involvement in systemic rheumatic diseases

An integrated view for the treating physicians

Kwang Seob Lee, Andreas Kronbichler, Michael Eisenhut, Keum Hwa Lee, Jaeil Shin

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Systemic autoimmune diseases can affect various kinds of organs including the kidney, the skin, soft tissue and the bone. Among others, cardiovascular involvement in rheumatic diseases has been shown to affect myocardium, pericardium, cardiac vessels, conduction system and valves, eventually leading to increased mortality. In general, underlying chronic inflammation leads to premature atherosclerosis, but also other manifestations such as arrhythmia and heart failure may have a 'silent’ progress. Traditional cardiovascular risk factors play a secondary role, while disease-specific factors (i.e. disease duration, severity, antibody positivity, persistent disease activity) can directly influence the cardiovascular system. Therefore, early diagnosis is critical to optimize management and to control inflammatory activity and recent data suggest that risk factors (i.e. hypercholesterolemia and hypertension) need intensive treatment as well. With the advent of immunosuppressive agents, most rheumatic diseases are well controlled on treatment, but information related to their cardioprotective efficacy is not well-defined. In this review, we focus on cardiovascular involvement in rheumatic diseases and highlight current evidence which should be of help for the treating physicians. Moreover, cardiotoxicity of immunosuppressive drugs is a rare issue and such potential adverse events will be briefly discussed.

Original languageEnglish
Pages (from-to)201-214
Number of pages14
JournalAutoimmunity Reviews
Volume17
Issue number3
DOIs
Publication statusPublished - 2018 Mar 1

Fingerprint

Rheumatic Diseases
Immunosuppressive Agents
Physicians
Pericardium
Cardiovascular System
Hypercholesterolemia
Autoimmune Diseases
Cardiac Arrhythmias
Early Diagnosis
Atherosclerosis
Myocardium
Heart Failure
Hypertension
Inflammation
Kidney
Bone and Bones
Skin
Mortality
Antibodies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Lee, Kwang Seob ; Kronbichler, Andreas ; Eisenhut, Michael ; Lee, Keum Hwa ; Shin, Jaeil. / Cardiovascular involvement in systemic rheumatic diseases : An integrated view for the treating physicians. In: Autoimmunity Reviews. 2018 ; Vol. 17, No. 3. pp. 201-214.
@article{45cec0b3be0f4a5b8e65dbe942c1b2c8,
title = "Cardiovascular involvement in systemic rheumatic diseases: An integrated view for the treating physicians",
abstract = "Systemic autoimmune diseases can affect various kinds of organs including the kidney, the skin, soft tissue and the bone. Among others, cardiovascular involvement in rheumatic diseases has been shown to affect myocardium, pericardium, cardiac vessels, conduction system and valves, eventually leading to increased mortality. In general, underlying chronic inflammation leads to premature atherosclerosis, but also other manifestations such as arrhythmia and heart failure may have a 'silent’ progress. Traditional cardiovascular risk factors play a secondary role, while disease-specific factors (i.e. disease duration, severity, antibody positivity, persistent disease activity) can directly influence the cardiovascular system. Therefore, early diagnosis is critical to optimize management and to control inflammatory activity and recent data suggest that risk factors (i.e. hypercholesterolemia and hypertension) need intensive treatment as well. With the advent of immunosuppressive agents, most rheumatic diseases are well controlled on treatment, but information related to their cardioprotective efficacy is not well-defined. In this review, we focus on cardiovascular involvement in rheumatic diseases and highlight current evidence which should be of help for the treating physicians. Moreover, cardiotoxicity of immunosuppressive drugs is a rare issue and such potential adverse events will be briefly discussed.",
author = "Lee, {Kwang Seob} and Andreas Kronbichler and Michael Eisenhut and Lee, {Keum Hwa} and Jaeil Shin",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.autrev.2017.12.001",
language = "English",
volume = "17",
pages = "201--214",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "3",

}

Cardiovascular involvement in systemic rheumatic diseases : An integrated view for the treating physicians. / Lee, Kwang Seob; Kronbichler, Andreas; Eisenhut, Michael; Lee, Keum Hwa; Shin, Jaeil.

In: Autoimmunity Reviews, Vol. 17, No. 3, 01.03.2018, p. 201-214.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Cardiovascular involvement in systemic rheumatic diseases

T2 - An integrated view for the treating physicians

AU - Lee, Kwang Seob

AU - Kronbichler, Andreas

AU - Eisenhut, Michael

AU - Lee, Keum Hwa

AU - Shin, Jaeil

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Systemic autoimmune diseases can affect various kinds of organs including the kidney, the skin, soft tissue and the bone. Among others, cardiovascular involvement in rheumatic diseases has been shown to affect myocardium, pericardium, cardiac vessels, conduction system and valves, eventually leading to increased mortality. In general, underlying chronic inflammation leads to premature atherosclerosis, but also other manifestations such as arrhythmia and heart failure may have a 'silent’ progress. Traditional cardiovascular risk factors play a secondary role, while disease-specific factors (i.e. disease duration, severity, antibody positivity, persistent disease activity) can directly influence the cardiovascular system. Therefore, early diagnosis is critical to optimize management and to control inflammatory activity and recent data suggest that risk factors (i.e. hypercholesterolemia and hypertension) need intensive treatment as well. With the advent of immunosuppressive agents, most rheumatic diseases are well controlled on treatment, but information related to their cardioprotective efficacy is not well-defined. In this review, we focus on cardiovascular involvement in rheumatic diseases and highlight current evidence which should be of help for the treating physicians. Moreover, cardiotoxicity of immunosuppressive drugs is a rare issue and such potential adverse events will be briefly discussed.

AB - Systemic autoimmune diseases can affect various kinds of organs including the kidney, the skin, soft tissue and the bone. Among others, cardiovascular involvement in rheumatic diseases has been shown to affect myocardium, pericardium, cardiac vessels, conduction system and valves, eventually leading to increased mortality. In general, underlying chronic inflammation leads to premature atherosclerosis, but also other manifestations such as arrhythmia and heart failure may have a 'silent’ progress. Traditional cardiovascular risk factors play a secondary role, while disease-specific factors (i.e. disease duration, severity, antibody positivity, persistent disease activity) can directly influence the cardiovascular system. Therefore, early diagnosis is critical to optimize management and to control inflammatory activity and recent data suggest that risk factors (i.e. hypercholesterolemia and hypertension) need intensive treatment as well. With the advent of immunosuppressive agents, most rheumatic diseases are well controlled on treatment, but information related to their cardioprotective efficacy is not well-defined. In this review, we focus on cardiovascular involvement in rheumatic diseases and highlight current evidence which should be of help for the treating physicians. Moreover, cardiotoxicity of immunosuppressive drugs is a rare issue and such potential adverse events will be briefly discussed.

UR - http://www.scopus.com/inward/record.url?scp=85041215535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041215535&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2017.12.001

DO - 10.1016/j.autrev.2017.12.001

M3 - Review article

VL - 17

SP - 201

EP - 214

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 3

ER -